You are here: Welcome to the MPKB » Welcome to the MPKB » Science behind Marshall Paradigm » Science behind olmesartan (Benicar) » Safety of olmesartan (Benicar)
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:protocol:olmesartan:safety [10.25.2018] – [Protective effects of olmesartan] sallieqhome:protocol:olmesartan:safety [12.29.2018] – [Notes and comments] sallieq
Line 88: Line 88:
 The most common reason that patients who begin the Marshall Protocol incorrectly assume that they are suffering from side effects of olmesartan is that they mistakenly attribute the hormonal adjustments that accompany the onset of a olmesartan blockade to side effects of the drug. These hormonal changes occur because in most patients with Th1 disease, the body has become accustomed to a higher than normal level of the hormone 1,25-D, which rises as part of the immune system’s reaction to bacteria. The most common reason that patients who begin the Marshall Protocol incorrectly assume that they are suffering from side effects of olmesartan is that they mistakenly attribute the hormonal adjustments that accompany the onset of a olmesartan blockade to side effects of the drug. These hormonal changes occur because in most patients with Th1 disease, the body has become accustomed to a higher than normal level of the hormone 1,25-D, which rises as part of the immune system’s reaction to bacteria.
  
-But the olmesartan blockade quickly and dramatically lowers 1,25-D - by as much as half in just two weeks. Since 1,25-D is a powerful hormone that affects nearly every cell in the body, and interacts with all the body’s major hormones, myriad other hormones are forced to adjust their levels according to the new lower level of 1,25-D. This often causes temporary neurological-type symptoms such as (but not limited to) fatigue, dizziness, headache, photosensitivity, irritability, sleep disturbances, brain fog, etc. As the body adjusts to this hormonal shift these symptoms dissipate, usually in a week or two.+But the olmesartan blockade quickly and dramatically lowers 1,25-D - by as much as half in just two weeks. Since 1,25-D is a powerful hormone that affects nearly every cell in the body, and interacts with all the body’s major hormones, myriad other hormones are forced to adjust their levels according to the new lower level of 1,25-D.  This often causes temporary neurological-type symptoms such as (but not limited to) fatigue, dizziness, headache, photosensitivity, irritability, sleep disturbances, brain fog, etc. As the body adjusts to this hormonal shift these symptoms dissipate, usually in a week or two.
  
 ==== Immunopathology ==== ==== Immunopathology ====
Line 148: Line 148:
  
  
-All these studies should be in the cancer article and link to each other:+ study should be in the cancer article and link to each other:  placed --- //Sallie Q 12.29.2018//
 <blockquote>Large registry study finds no excess cancer risk with ARB use <blockquote>Large registry study finds no excess cancer risk with ARB use
 By Joanna Lyford By Joanna Lyford
home/protocol/olmesartan/safety.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.